Aberrant DNA Methylation in Human Cancers

被引：0
|
作者：
黎文 [1 ]
陈碧峰 [2 ]
机构：
[1] Editorial Department of Journal of Clinical Surgery,Hubei Medical Association
[2] School of Biomedical Sciences,Faculty of Medicine,The Chinese University of Hong Kong
来源：
Current Medical Science | 2013年 / 06期
关键词：
epigenetics; aberrant DNA methylation; human cancers; treatment;
D O I：
暂无
中图分类号：
R730.2 [肿瘤病理学、病因学];
学科分类号：
100214 ;
摘要：
DNA methylation,one of the best-characterized epigenetic modifications,plays essential roles in diseases,including human cancers.In recent years,our understanding on DNA methylation with human cancers has made significant progress,which was facilitated by stunning development in the analysis of the human methylome of multiple cancer types.In this review,recent developments in the characterization of aberrant DNA methylation involved in human cancers development were discussed with special emphasis on the mechanisms of aberrant DNA methylation in human cancers.We also summarize the recent treatment strategy for human cancers with de-methylation drugs.
引用
收藏
页码：798 / 804
页数：7
相关论文
共 50 条
  • [1] Aberrant DNA Methylation in Human Cancers
    Li, Wen
    Chen, Bi-feng
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2013, 33 (06) : 798 - 804
  • [2] Aberrant DNA methylation in human cancers
    Wen Li
    Bi-feng Chen
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2013, 33 : 798 - 804
  • [3] Aberrant methylation of SPARC in human lung cancers
    M Suzuki
    C Hao
    T Takahashi
    H Shigematsu
    N Shivapurkar
    U G Sathyanarayana
    T Iizasa
    T Fujisawa
    K Hiroshima
    A F Gazdar
    British Journal of Cancer, 2005, 92 : 942 - 948
  • [4] Aberrant methylation of SPARC in human lung cancers
    Suzuki, M.
    Hao, C.
    Takahashi, T.
    Shigematsu, H.
    Shivapurkar, N.
    Sathyanarayana, U. G.
    Iizasa, T.
    Fujisawa, T.
    Hiroshima, K.
    Gazdar, A. F.
    BRITISH JOURNAL OF CANCER, 2013, 108 (03) : 744 - 744
  • [5] MethCancerDB – aberrant DNA methylation in human cancer
    M Lauss
    I Visne
    A Weinhaeusel
    K Vierlinger
    C Noehammer
    A Kriegner
    British Journal of Cancer, 2008, 98 : 816 - 817
  • [6] MethCancerDB - aberrant DNA methylation in human cancer
    Lauss, M.
    Visne, I.
    Weinhaeusel, A.
    Vierlinger, K.
    Noehammer, C.
    Kriegner, A.
    BRITISH JOURNAL OF CANCER, 2008, 98 (04) : 816 - 817
  • [7] Aberrant methylation of CpG islands in human breast cancers.
    Miyamoto, K.
    Koseki, M.
    Hatanaka, N.
    Kamiike, W.
    Taniyama, K.
    Ushijima, T.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S249 - S250
  • [8] Retraction Note: Aberrant methylation of SPARC in human lung cancers
    M Suzuki
    C Hao
    T Takahashi
    H Shigematsu
    N Shivapurkar
    U G Sathyanarayana
    T Iizasa
    T Fujisawa
    K Hiroshima
    A F Gazdar
    British Journal of Cancer, 2013, 108 : 744 - 744
  • [9] Effect of decitabine on DNA methylation in human cancers
    Stewart, David J.
    Kurzrock, Razelle
    Oki, Yasuhiro
    Camacho, Luis H.
    Gupta, Sanjay
    Wistuba, Ignacio Ivan
    Pilat, Susan R.
    Guo, Zhong
    Pean-Pierre, Issa
    CANCER RESEARCH, 2006, 66 (08)
  • [10] Dissecting the role of aberrant DNA methylation in human leukaemia
    Amabile, Giovanni
    Di Ruscio, Annalisa
    Mueller, Fabian
    Welner, Robert S.
    Yang, Henry
    Ebralidze, Alexander K.
    Zhang, Hong
    Levantini, Elena
    Qi, Lihua
    Martinelli, Giovanni
    Brummelkamp, Thijn
    Le Beau, Michelle M.
    Figueroa, Maria E.
    Bock, Christoph
    Tenen, Daniel G.
    NATURE COMMUNICATIONS, 2015, 6
12345